JP2005508350A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508350A5 JP2005508350A5 JP2003534397A JP2003534397A JP2005508350A5 JP 2005508350 A5 JP2005508350 A5 JP 2005508350A5 JP 2003534397 A JP2003534397 A JP 2003534397A JP 2003534397 A JP2003534397 A JP 2003534397A JP 2005508350 A5 JP2005508350 A5 JP 2005508350A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- defined above
- derivatives
- group
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000006850 spacer group Chemical group 0.000 claims description 4
- 238000000034 method Methods 0.000 claims 9
- 125000001424 substituent group Chemical group 0.000 claims 5
- -1 -COOR Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 238000007127 saponification reaction Methods 0.000 claims 3
- IMTUBZOIPOXUTD-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) quinoline-2-carboxylate Chemical compound C=1C=C2C=CC=CC2=NC=1C(=O)ON1C(=O)CCC1=O IMTUBZOIPOXUTD-UHFFFAOYSA-N 0.000 claims 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 230000020477 pH reduction Effects 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- GFYMLRYNGZEAFF-UHFFFAOYSA-N 2-[(3,4-dihydroxyphenyl)methylcarbamoyl]-8-hydroxyquinoline-7-carboxylic acid Chemical compound N=1C2=C(O)C(C(=O)O)=CC=C2C=CC=1C(=O)NCC1=CC=C(O)C(O)=C1 GFYMLRYNGZEAFF-UHFFFAOYSA-N 0.000 claims 1
- GKHAQRADKBTIKK-UHFFFAOYSA-N 2-carbamoyl-8-hydroxyquinoline-7-carboxylic acid Chemical class C1=CC(C(O)=O)=C(O)C2=NC(C(=O)N)=CC=C21 GKHAQRADKBTIKK-UHFFFAOYSA-N 0.000 claims 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- 230000002411 adverse Effects 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003248 quinolines Chemical class 0.000 claims 1
- 159000000000 sodium salts Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0113209A FR2830863B1 (fr) | 2001-10-12 | 2001-10-12 | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
| PCT/FR2002/003512 WO2003031413A1 (fr) | 2001-10-12 | 2002-10-14 | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508350A JP2005508350A (ja) | 2005-03-31 |
| JP2005508350A5 true JP2005508350A5 (https=) | 2006-01-05 |
Family
ID=8868255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003534397A Pending JP2005508350A (ja) | 2001-10-12 | 2002-10-14 | キノリン誘導体、合成法およびこれらの誘導体を含有する薬剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7064133B2 (https=) |
| EP (1) | EP1461319B1 (https=) |
| JP (1) | JP2005508350A (https=) |
| AT (1) | ATE430134T1 (https=) |
| DE (1) | DE60232186D1 (https=) |
| DK (1) | DK1461319T3 (https=) |
| ES (1) | ES2326115T3 (https=) |
| FR (1) | FR2830863B1 (https=) |
| IL (2) | IL161320A0 (https=) |
| WO (1) | WO2003031413A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2830863B1 (fr) * | 2001-10-12 | 2004-01-30 | Bioalliance Pharma | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
| FR2839646B1 (fr) * | 2002-05-17 | 2008-04-11 | Bioalliance Pharma | Utilisation de derives de quinoleine a effet anti-integrase et ses applications |
| US7132432B2 (en) * | 2003-06-05 | 2006-11-07 | Bristol-Myers Squibb Company | Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE) |
| TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| US20070185007A1 (en) | 2003-09-19 | 2007-08-09 | Haolun Jin | Aza-quinolinol phosphonate integrase inhibitor compounds |
| US20080280849A1 (en) * | 2005-06-01 | 2008-11-13 | Herve Leh | Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2761687B1 (fr) * | 1997-04-08 | 2000-09-15 | Centre Nat Rech Scient | Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques |
| FR2830863B1 (fr) * | 2001-10-12 | 2004-01-30 | Bioalliance Pharma | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
-
2001
- 2001-10-12 FR FR0113209A patent/FR2830863B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-14 IL IL16132002A patent/IL161320A0/xx unknown
- 2002-10-14 WO PCT/FR2002/003512 patent/WO2003031413A1/fr not_active Ceased
- 2002-10-14 DK DK02795314T patent/DK1461319T3/da active
- 2002-10-14 ES ES02795314T patent/ES2326115T3/es not_active Expired - Lifetime
- 2002-10-14 AT AT02795314T patent/ATE430134T1/de not_active IP Right Cessation
- 2002-10-14 JP JP2003534397A patent/JP2005508350A/ja active Pending
- 2002-10-14 EP EP02795314A patent/EP1461319B1/fr not_active Expired - Lifetime
- 2002-10-14 US US10/492,088 patent/US7064133B2/en not_active Expired - Fee Related
- 2002-10-14 DE DE60232186T patent/DE60232186D1/de not_active Expired - Lifetime
-
2004
- 2004-04-07 IL IL161320A patent/IL161320A/en not_active IP Right Cessation
-
2006
- 2006-03-01 US US11/364,329 patent/US20060148849A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008511601A5 (https=) | ||
| JP4634560B2 (ja) | 光学活性なインドリン誘導体の製造方法およびその製造中間体 | |
| JP2005526011A5 (https=) | ||
| JP2005525330A5 (https=) | ||
| JP2006512301A5 (https=) | ||
| JPH11302257A5 (https=) | ||
| CY1115696T1 (el) | Μεθοδος για την παρασκευη υποκατεστημενου με διαρυλιο 4-αμινο-βουτυρικου οξεος ή παραγωγων του και η χρηση τους για την παρασκευη αναστολεων νερ | |
| JPH10265454A5 (https=) | ||
| WO2008093024A3 (fr) | Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2-carboxamides, leur préparation et leur application en therapeutique | |
| JP2002513793A5 (https=) | ||
| JP2007516286A5 (https=) | ||
| JP2004505965A5 (https=) | ||
| JP2005508350A5 (https=) | ||
| JP2004529172A5 (https=) | ||
| JP2009539822A5 (https=) | ||
| RU2003134629A (ru) | Соединения цефема | |
| JP2008540414A5 (https=) | ||
| JP4208464B2 (ja) | ナフチリジン−３−カルボン酸誘導体の製造法 | |
| JP2008545655A (ja) | 一酸化窒素供与体ジアゼン−１−イウム−１，２−ジオラート部分を有する新規非ステロイド系抗炎症薬 | |
| JP2006517932A5 (https=) | ||
| JP7109056B2 (ja) | Ｓ－ｉｃａリボシルホモシステインの製造方法 | |
| JP3125101B2 (ja) | 光学異性ヒダントインの分割方法 | |
| ES2167869T3 (es) | Procedimiento para preparar acidos nicotinicos. | |
| HUP0401404A2 (hu) | (R)-(-)-2-hidroxi-2-(2-klórfenil)-ecetsav rezolválási eljárása | |
| JP2004224802A (ja) | 抗菌剤 |